JP Morgan Chase
WVE icon

JP Morgan Chase’s Wave Life Sciences WVE Stock Holding History

JP Morgan Chase’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-28,800
Closed -$756K – 5986
2019
Q2 		$756K Buy
28,800
+11,800
+69% +$331K ﹤0.01% 4015
2019
Q1 		$660K Buy
+17,000
New +$690K ﹤0.01% 4048

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase's WVE Position: Q1 2026 in Review

JP Morgan Chase reduced its Wave Life Sciences (WVE) stake by 25% in Q1 2026, selling an estimated $2.9M and leaving 670,170 shares worth $4.44M. The position accounts for ﹤0.01% of the portfolio, ranked #3428.

JP Morgan Chase first reported a position in WVE in Q4 2016 and has held it in 37 quarters since. The position peaked at $15.2M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • JP Morgan Chase held 670,170 shares of Wave Life Sciences worth $4.44M as of Q1 2026.
  • JP Morgan Chase sold 222,716 Wave Life Sciences shares in Q1 2026, an estimated $2.9M.
  • Wave Life Sciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #3428 holding.
  • JP Morgan Chase first reported a position in Wave Life Sciences in Q4 2016 and has held it in 37 quarters since.
  • JP Morgan Chase's Wave Life Sciences position peaked at $15.2M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.